Monthly Archives: February 2014

Diabetic foot ulcers healed, amputation prevented by tissue repair drug

Patients were twice as likely to have a diabetic foot ulcer heal within eight weeks when they were treated with a tissue repair drug versus a placebo, according to new research accepted for publication in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).Foot ulcers are a common complication from diabetes than can lead to hospitalization and lower limb amputation.

Indoor tanning common among high-schoolers, linked to other risky behavior

A national survey of high school students finds that indoor tanning is a common practice, particularly among female, older and non-Hispanic white students, and is associated with several other risky health-related behaviors, according to a study by Gery P. Guy Jr., Ph.D., M.P.H., of the Centers for Disease Control and Prevention, Atlanta, and colleagues.

Did a risk of skin cancer drive the evolution of black skin in humans?

A new analysis suggests that black skin may have evolved in humans as a protective measure against skin cancer.Previously, skin cancer has been disregarded as an influence in the evolution of black skin in humans. This is based on the belief that skin cancer only rarely causes death at ages young enough to affect reproduction.

Promising skin tumor vaccine offers hope for transplant patients

Papillomaviruses (linked to cervical cancer when they infect the mucosal tissue in the female reproductive tract) can also infect normal skin, where they cause warts and possibly non-melanoma skin cancer, mostly in immune-suppressed organ transplant patients. An article published in PLOS Pathogens suggests that vaccination might prevent virus-associated benign and malignant skin tumors.

Parcell Laboratories partners with the University of Pittsburgh medical center to study effective stem cell-based wrinkle treatments

Parcell Laboratories, developer of novel therapeutics based on its patented adult stem cell platform technology, the ELA® cell, is partnering with the University of Pittsburgh Medical Center (UPMC) to study a new stem cell-based wrinkle reduction treatment.